CD44 enhances tumor formation and lung metastasis in experimental osteosarcoma and is an additional predictor for poor patient outcome.

MLA

Gvozdenovic, Ana, et al. “CD44 Enhances Tumor Formation and Lung Metastasis in Experimental Osteosarcoma and Is an Additional Predictor for Poor Patient Outcome.” Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, vol. 28, no. 4, Apr. 2013, pp. 838–47. EBSCOhost, https://doi.org/10.1002/jbmr.1817.

APA

Gvozdenovic, A., Arlt, M. J. E., Campanile, C., Brennecke, P., Husmann, K., Li, Y., Born, W., Muff, R., & Fuchs, B. (2013). CD44 enhances tumor formation and lung metastasis in experimental osteosarcoma and is an additional predictor for poor patient outcome. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, 28(4), 838–847. https://doi.org/10.1002/jbmr.1817

Chicago

Gvozdenovic, Ana, Matthias J E Arlt, Carmen Campanile, Patrick Brennecke, Knut Husmann, Yufei Li, Walter Born, Roman Muff, and Bruno Fuchs. 2013. “CD44 Enhances Tumor Formation and Lung Metastasis in Experimental Osteosarcoma and Is an Additional Predictor for Poor Patient Outcome.” Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 28 (4): 838–47. doi:10.1002/jbmr.1817.